by David Schwartz J.D. CPA | Jul 24, 2012 | All, Change Overview and Rationale, Formal Regulatory Remedies
The Basel Committee on Banking Supervision and the International Organization of Securities Commissions (IOSCO) jointly have published a consultative paper on margin requirements for non-centrally-cleared derivatives. The paper presents the initial policy proposals...
by David Schwartz J.D. CPA | Jul 20, 2012 | All, Formal Regulatory Remedies
Following the approval on July 11 by the Commodity Futures Trading Commission of the definitional rules for “swaps” and other derivatives products, and defining the “end user exemption,” the compliance dates for many of the CFTC’s...
by David Schwartz J.D. CPA | Jun 19, 2012 | All, Change Overview and Rationale, Formal Regulatory Remedies
In their communiqué from June’s Los Cabos meeting, the G20 said that it expects member nations to finalize their OTC derivatives regulations in order to meet the the G20’s fast approaching deadline. The communiqué urges member nations to fast track their...
by David Schwartz J.D. CPA | Jun 19, 2012 | All, Change Overview and Rationale, Formal Regulatory Remedies, Procedural Changes
OTC derivatives legislation and clearing reforms understandably have European and US market participants scratching their heads about what this “sea of change” has in store for them and the future of OTC markets. David Felsenthal, a partner at Clifford...
by David Schwartz J.D. CPA | May 28, 2012 | All, Change Overview and Rationale, Formal Regulatory Remedies
Verena Ross, Executive Director of the European Securities and Markets Authority, says that the EU will lead by example in the harmonization and convergence of regulation of OTC derivatives. With the plan for the EU regulation of OTC derivatives, central...
